SecBot SecBot
PRESS-RELEASE ·Filed Aug 12, 2026

DERM

Journey Medical Corporation
BEARISH
Impact 6/10
Horizondays Processed2mo ago WireGlobeNewswire
Press release · Earnings
Actionable Insight ▼ Bearish

The sharp EPS miss overshadows the modest revenue beat. Watch for analyst downgrades and any guidance updates in the next 8-K. The stock may face selling pressure as the market reprices earnings expectations.

DirectionBearish
Confidencehigh
Horizondays
Latest settled — T+20d ⚠ clustered
DERM ▲ +8.72% at T+20d
SHORT call ✗ call lost -8.72% · α vs SPY -10.47% · entry $6.65 → $7.23
Next anchor: T+60d in 10d
Latest observation: T+50 +11.82% FF3 residual α
Entry = T+0 close
Aug 12, 2026
via day close
T+1d
+1.05%
call -1.05% · α -1.25%
$6.72
settled 2mo ago
T+5d
+12.63%
call -12.63% · α -14.60%
$7.49
settled 2mo ago
T+20d
+8.72%
call -8.72% · α -10.47%
$7.23
settled 7w ago
T+60d
Pending
in 10d

Price Chart

Loading chart...

Executive Summary

Journey Medical reported Q1 2026 EPS of -$0.08, a 255.6% miss vs consensus of -$0.02, with revenue of $18.5M slightly above the $18.4M estimate. The significant earnings miss, despite modest revenue growth, signals deteriorating profitability and likely weighs on the stock near-term.

Key Financial Metrics

EPS
−$0.08
est −$0.02 · -255.6%
Revenue
$18.5M
est $18.4M · +0.5% · +23.0% YoY
Rating
strong miss

Key Facts

  • EPS of -$0.08 missed consensus of -$0.02 by 255.6%
  • Revenue of $18.5M slightly beat consensus of $18.4M
  • Revenue grew 23% year-over-year
  • EPS miss was the largest in the last four quarters

Financial Impact

EPS miss of $0.06 per share vs consensus

epsprofitability

Risk Factors

  • Further earnings misses if cost pressures persist
  • Potential analyst downgrades or price target cuts

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
90% bullish (10 analysts)

Investment Themes

Documents Analyzed

This report is based on 1 press release from GlobeNewswire.

DocumentAccession Number
PRESS-RELEASE Data (Synthetic)press-3344038
9 reports for DERM
Performance horizon
75% Hit rate @ T+20 3 of 4 directional calls Went positive at some point 3 of 4 best @ T+60▲ +44.51%Apr 21, 2026
Filters
Rows
Reports for DERM — sortable, filterable
TypeNow
Oct 9, 2026
17d ago
SC 13G/A
NEUTRAL ★ 4/10
$6.31awaiting T+20—$4.97 (−21.24%)
Aug 15, 2026
10w ago
Institutional Cluster
MIXED ★ 4/10
$6.46 $7.36▲ +13.93%▲ +15.91%$4.97 (−23.07%)
Aug 12, 2026
10w ago
8-K
BULLISH ★ 6/10
$6.65 $7.23▲ +8.72%▲ +10.47%$4.97 (−25.26%)
Aug 12, 2026
10w ago
Press Release
BEARISH ★ 6/10
$6.65 $7.23▼ −8.72%▼ −10.47%$4.97 (+25.26%)
May 13, 2026
23w ago
8-K
BULLISH ★ 6/10
$6.35 $6.34▼ −0.16%▲ +0.70%$4.97 (−21.73%)
May 6, 2026
24w ago
Press Release
NEUTRAL ★ 1/10
$5.00 $6.06▲ +21.20%▲ +18.06%$4.97 (−0.60%)
Apr 21, 2026
26w ago
Press Release
BULLISH ★ 6/10
$4.92 $6.25▲ +27.03%▲ +22.12%$4.97 (+1.02%)
Mar 25, 2026
30w ago
Press Release
BULLISH ★ 7/10
$4.78 $5.15▲ +7.74%▼ −2.92%$4.97 (+3.97%)
Mar 18, 2026
31w ago
Press Release
NEUTRAL ★ 3/10
$7.12 $5.17▼ −27.39%▼ −33.43%$4.97 (−30.20%)
Showing 9 of 9

US Market Status

Market Closed — Opens Tue (< 1m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Aug 12, 2026